Schedule 13G ownership disclosure

Arcus Biosciences Inc

Security class unavailable · CUSIP: 03969F109

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,035,170
Percent of class
13.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001086364-24-001338
Form type
SC 13G/A
Filer
Arcus Biosciences, Inc.
CIK
CIK 1724521
Filed
Jan 23, 2024
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub